The Brown University Psychopharmacology Update Template
Write in a clean editor, then format for The Brown University Psychopharmacology Update in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the The Brown University Psychopharmacology Update format
The Brown University Psychopharmacology Update is a peer-reviewed journal published by Wiley, covering Attention Deficit Hyperactivity Disorder, Treatment of Major Depression, Schizophrenia research and treatment.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." The Brown University Psychopharmacology Update 12 (3): 45–58.
Formats any DOI in The Brown University Psychopharmacology Update style. No sign-up. |
| Publishes research in | Attention Deficit Hyperactivity Disorder Treatment of Major Depression Schizophrenia research and treatment Pharmaceutical studies and practices Bipolar Disorder and Treatment |
| ISSN | 1068-5308 |
| Citation impact (2-yr) | 0.01 |
| h-index | 3 |
| i10-index | 1 |
| Total citations | 110 |
| Top institutions publishing here | John Brown University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in The Brown University Psychopharmacology Update per year
Citation impact of The Brown University Psychopharmacology Update by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in The Brown University Psychopharmacology Update
This month, we break with tradition by offering up a commentary that is not tied to any specific article covered in this month's issue of The Update . Instead, I'm going to address some developments in psychopharmacology over the past few months that represent a major departure from business as usual in American clinical psychiatry.
The etiology of breast cancer is complicated and not fully understood. In addition to genetic influences, however, it is believed that disturbances in the secretion of prolactin, which regulates differentiation, proliferation, and survival of mammary gland epithelial cells, could play a role.
It is not unusual for patients to exhibit depressive symptoms after suffering a stroke. Although effective in managing depression, some antidepressants are believed to carry a risk of additional adverse cardiovascular and cerebrovascular effects, as well as the potential for drug‐drug interaction. Such adverse effects include conduction abnormalities and sudden death from the use of…